Plain-English translation of NCT04165109 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is building a group of healthy adults with Down syndrome who are willing to participate in future Alzheimer's disease research. Researchers will follow these participants over time, measuring thinking and memory skills, taking brain scans, and collecting blood or spinal fluid samples. The goal is to understand how Alzheimer's disease develops in people with Down syndrome so that future treatment trials can be designed more effectively.
People with Down syndrome are at higher risk for developing Alzheimer's disease earlier in life than the general population, but there is limited research on how the disease progresses in this group. By studying healthy adults now, researchers hope to identify the earliest warning signs and develop better ways to test new treatments in future clinical trials.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
Participants will have regular visits where they complete cognitive and memory tests, answer questions about their health history, and undergo brain imaging (MRI scans). They will also provide blood samples and possibly spinal fluid samples for biomarker testing. The study will track participants over time to see how their thinking and memory change. Participants can also choose to be enrolled in a companion study (ABC-DS) and will be invited to join future Alzheimer's clinical trials when they become available.
AI-generated summary from trial data ยท Jun 19, 2026 ยท Not medical advice
United States